Literature DB >> 22497983

Retrograde endoureterotomy for persistent ureterovesical anastomotic strictures in renal transplant kidneys after failed antegrade balloon dilation.

Roy Mano1, Shay Golan, Ronen Holland, Pinhas M Livne, David A Lifshitz.   

Abstract

OBJECTIVE: To evaluate the long-term outcomes and complications of retrograde endoureterotomy for persistent ureterovesical anastomotic strictures in renal transplant patients after percutaneous balloon dilation failure.
METHODS: From January 2000 to May 2010, 26 (2.6%) of 1004 renal transplant patients developed ureterovesical anastomotic stricture after surgery. Seven of these patients and five additional referred patients with similar characteristics were treated with retrograde endoureterotomy after ≥1 previous unsuccessful attempt at percutaneous balloon dilation. All strictures treated were <1 cm in length. The clinical characteristics and outcomes were analyzed. Success was defined as the absence of symptoms and the resolution of obstruction on imaging after the procedure.
RESULTS: The median interval from initial treatment to endoureterotomy was 2.9 months (range 1.3-62.1). Before endoscopic treatment, 8 patients (67%) were treated with a single trial of balloon dilation and 4 (33%) with multiple trials. Endoureterotomy was performed using cold knife, holmium:yttrium-aluminum-garnet laser, and Bugbee electrode in 9, 2, and 1 patients, respectively. The median follow-up period was 44.4 months (range 2.4-68.6). Recurrent stricture developed in 2 patients during a mean follow-up of 4.7 months. Thus, the overall success rate was 83%. Postoperative complications appeared in 3 patients (25%) with culture-positive urinary tract infection. One graft failure occurred but was not related to a recurrent stricture.
CONCLUSION: After failure of antegrade percutaneous balloon dilation, retrograde endoureterotomy is an effective salvage procedure for well-selected cases of renal transplant patients with a short ureterovesical anastomotic stricture.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22497983     DOI: 10.1016/j.urology.2012.02.030

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Current status of minimally invasive endoscopic management of ureteric strictures.

Authors:  Stefanos Kachrilas; Andreas Bourdoumis; Theocharis Karaolides; Stavroula Nikitopoulou; George Papadopoulos; Noor Buchholz; Junaid Masood
Journal:  Ther Adv Urol       Date:  2013-12

Review 2.  Endoscopic Management of Ureteral Strictures: an Update.

Authors:  Jacob W Lucas; Eric Ghiraldi; Jeffrey Ellis; Justin I Friedlander
Journal:  Curr Urol Rep       Date:  2018-03-02       Impact factor: 3.092

Review 3.  The current role of endourologic management of renal transplantation complications.

Authors:  Brian D Duty; Michael J Conlin; Eugene F Fuchs; John M Barry
Journal:  Adv Urol       Date:  2013-08-19

Review 4.  The development and current status of minimally invasive surgery to manage urological complications after renal transplantation.

Authors:  Ravindra B Sabnis; Abhishek G Singh; Arvind P Ganpule; Jaspreet S Chhabra; Gopal R Tak; Jaimin H Shah
Journal:  Indian J Urol       Date:  2016 Jul-Sep

Review 5.  Diagnosis and management of ureteral complications following renal transplantation.

Authors:  Brian D Duty; John M Barry
Journal:  Asian J Urol       Date:  2015-08-24

6.  Routine double-J stenting for live related donor kidney transplant recipients: It doesn't serve the purpose, but does it serve a better purpose?

Authors:  Vikash Kumar; Chirag B Punatar; Kunal K Jadhav; Jatin Kothari; Vinod S Joshi; Sharad N Sagade; Madhav H Kamat
Journal:  Investig Clin Urol       Date:  2018-10-22

7.  Retrograde ureteric stent insertion from percutaneous suprapubic access to the bladder in renal transplant recipients with ureteric stenosis: a novel minimally invasive technique.

Authors:  Jian-Hui Wu; Chun-Bai Mo; Li Dong-Zhai; Fei Luo; Qing-Tong Ma; Shi-Qiang Yang
Journal:  BMC Urol       Date:  2020-11-02       Impact factor: 2.264

8.  Sometimes the communications are of special value.

Authors:  Marcin Słojewski
Journal:  Cent European J Urol       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.